For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| General and administrative costs | 2,816,013 | |||
| Loss from operations | -2,816,013 | |||
| Interest earned on cash and investments held in trust account | 8,756,656 | |||
| Total other income | 8,756,656 | |||
| Net income (loss) | 5,940,643 | |||
| Basic EPS | 0.19 | |||
| Diluted EPS | 0.19 | |||
| Basic Average Shares | 21,008,219 | |||
| Diluted Average Shares | 21,008,219 | |||
Drugs Made In America Acquisition Corp. (DMAA)
Drugs Made In America Acquisition Corp. (DMAA)